Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults Implications for Primary Prevention

BACKGROUND Coronary artery disease (CAD) has substantial heritability and a polygenic architecture. However, the potential of genomic risk scores to help predict CAD outcomes has not been evaluated comprehensively, because available studies have involved limited genomic scope and limited sample sizes. OBJECTIVES This study sought to construct a genomic risk score for CAD and to estimate its potential as a screening tool for primary prevention. METHODS Using a meta-analytic approach to combine large-scale, genome-wide, and targeted genetic association data, we developed a new genomic risk score for CAD (metaGRS) consisting of 1.7 million genetic variants. We externally tested metaGRS, both by itself and in combination with available data on conventional risk factors, in 22,242 CAD cases

[1]  P. Donnelly,et al.  Genome-wide genetic data on ~500,000 UK Biobank participants , 2017, bioRxiv.

[2]  C. Sudlow,et al.  Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population , 2017, American journal of epidemiology.

[3]  A. Khera,et al.  Genetics of coronary artery disease: discovery, biology and clinical translation , 2017, Nature Reviews Genetics.

[4]  Dermot F. Reilly,et al.  Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting , 2017, Circulation.

[5]  M. Kubát.  An Introduction to Machine Learning , 2017, Springer International Publishing.

[6]  E. Boerwinkle,et al.  Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease. , 2016, The New England journal of medicine.

[7]  Jianxin Shi,et al.  Developing and evaluating polygenic risk prediction models for stratified disease prevention , 2016, Nature Reviews Genetics.

[8]  Markus Perola,et al.  Genomic prediction of coronary heart disease , 2016, bioRxiv.

[9]  J. Catanese,et al.  Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history , 2015, European heart journal.

[10]  Andrea Ganna,et al.  5 year mortality predictors in 498 103 UK Biobank participants: a prospective population-based study , 2015, The Lancet.

[11]  M. Inouye,et al.  Genomic risk prediction of complex human disease and its clinical application. , 2015, Current opinion in genetics & development.

[12]  Olle Melander,et al.  Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials , 2015, The Lancet.

[13]  T. Hansen,et al.  A genetic risk score of 45 coronary artery disease risk variants associates with increased risk of myocardial infarction in 6041 Danish individuals. , 2015, Atherosclerosis.

[14]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[15]  V. Salomaa,et al.  Genetic Risk Prediction and a 2-Stage Risk Screening Strategy for Coronary Heart Disease , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[16]  F. Dudbridge.  Power and Predictive Accuracy of Polygenic Risk Scores , 2013, PLoS genetics.

[17]  Lu Qi,et al.  Genetic Risk Score and Risk of Myocardial Infarction in Hispanics , 2011, Circulation.

[18]  L. Peltonen,et al.  A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses , 2010, The Lancet.

[19]  Martin Farrall,et al.  Genetic susceptibility to coronary artery disease: from promise to progress , 2006, Nature Reviews Genetics.

[20]  Thomas Lengauer,et al.  ROCR: visualizing classifier performance in R , 2005, Bioinform..

[21]  P. Grambsch,et al.  A Package for Survival Analysis in S , 1994 .